7-[4-(N-ACETYL-N-ETHYL)-AMINOPHENYL]-6-ETHOXYCARBONYL-1,2,4-TRIAZOLO-[1,5-A]-PYRIMIDINE
Compound with spectra: 1 NMR
![7-[4-(N-ACETYL-N-ETHYL)-AMINOPHENYL]-6-ETHOXYCARBONYL-1,2,4-TRIAZOLO-[1,5-A]-PYRIMIDINE](/api/compound/B8E90VH9ovt.png?ph=true&h=300&w=458 "7-[4-(N-ACETYL-N-ETHYL)-AMINOPHENYL]-6-ETHOXYCARBONYL-1,2,4-TRIAZOLO-[1,5-A]-PYRIMIDINE")
| SpectraBase Compound ID | B8E90VH9ovt |
|---|---|
| InChI | InChI=1S/C18H19N5O3/c1-4-22(12(3)24)14-8-6-13(7-9-14)16-15(17(25)26-5-2)10-19-18-20-11-21-23(16)18/h6-11H,4-5H2,1-3H3 |
| InChIKey | PYHMMARLQFZLFD-UHFFFAOYSA-N |
| Mol Weight | 353.38 g/mol |
| Molecular Formula | C18H19N5O3 |
| Exact Mass | 353.148789 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
7-[4-(N-ACETYL-N-ETHYL)-AMINOPHENYL]-6-ETHOXYCARBONYLPYRAZOLO-[1,5-A]-PYRIMIDINE
[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylic acid, 5-hydroxy-7-methyl-2-(phenylamino)-, ethyl ester
[1,2,4]triazolo[1,5-a]pyrimidine, 6-[3-(2,3-dihydro-1H-indol-1-yl)-3-oxopropyl]-2,5,7-trimethyl-
N-[3-(3-CARBOXAMIDOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYLACETAMIDE;IMPURITY_II;ZALEPLON-CARBOXAMIDE
Ethyl 2-(4-amino-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6(7H)-ylidene)-3-iminopropanoate
1H-pyrrole-3-carboxylic acid, 1-(4-ethoxyphenyl)-4,5-dihydro-2-methyl-4-[(4-methylphenyl)methylene]-5-oxo-, ethyl ester, (4Z)-
3,6-Bis(3-(3-bromophenylamino)-4-ethoxycarbonyl-5-oxo-2,5-dihydroisoxazolin-2-yl)pyridazine
N-[5,7-bis(4-chlorophenyl)-4,5,6,7-tetrahydro[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-2-(4-methoxyphenyl)acetamide
1H-isoindole-5-carboxamide, 2,3-dihydro-N-(4-methoxy-2-nitrophenyl)-2-(4-methylphenyl)-1,3-dioxo-
5-(4-Methoxybenzylidene)-3-phenyl-2-(8-quinolinoxy)-4H-imidazolin-4-one
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of pyrazolo[1,5-a]-, 1,2,4-triazolo[1,5-a]- and imidazo[1,2-a]pyrimidines related to zaleplon, a new drug for the treatment of insomnia | Journal of Heterocyclic Chemistry | 2001 |